A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade Gliomas
- Olivier Rixe
- , John L. Villano
- , Robert Wesolowski
- , Anne M. Noonan
- , Vinay K. Puduvalli
- , Trisha M. Wise-Draper
- , Richard Curry
- , Emrullah Yilmaz
- , Charlie Cruze
- , Besim Ogretmen
- , Gilles Tapolsky
- , Ray Takigiku
Producción científica: Article › revisión exhaustiva
4
Citas
(Scopus)